Recruiting Lung Cancer Studies in Yuma
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
This study is researching an investigational drug called fianlimab (also called REGN3767) with two other medications called cemiplimab and chemotherapy, individually called a "study drug" or collectiv...
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected Stage II, IIIA, IIIB (...
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
This study is researching an experimental drug called fianlimab (also called REGN3767), combined with a medication called cemiplimab (also called REGN2810), individually called a "study drug" or colle...
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues...
About Lung Cancer Clinical Trials in Yuma
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 4 lung cancer clinical trials recruiting participants in Yuma, ARIZONA. These studies are seeking a combined 3,366 participants. Research is being sponsored by Regeneron Pharmaceuticals, Merck Sharp & Dohme LLC, AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Yuma — FAQ
Are there lung cancer clinical trials in Yuma?
Yes, there are 4 lung cancer clinical trials currently recruiting in Yuma, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Yuma?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Yuma research site will contact you about next steps.
Are clinical trials in Yuma free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Yuma studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 4 active trials in Yuma are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov